Genetic variants in FCGR2A and FCGR3A and disease-free survival in patients with HER2 positive breast cancer treated with trastuzumab in the SUCCESS A trial
Senologie - Zeitschrift für Mammadiagnostik und -therapie | July 5, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1055/s-0038-1651824